Altered RNA Splicing by Mutant p53 Activates Oncogenic RAS Signaling in Pancreatic Cancer
Luisa F. Escobar‐Hoyos, Alex Penson, Ram Kannan, Hana Cho, Chun‐Hao Pan, Rohit K. Singh, Lisa Helene Apken, G. Aaron Hobbs, Renhe Luo, Nicolas Lecomte, Sruthi Babu, Fong Cheng Pan, Direna Alonso‐Curbelo, John P. Morris, Gökçe Aşkan, Olivera Grbovic-Huezo, Paul Ogrodowski, Jonathan Bermeo, Joseph A. Saglimbeni, Cristian D. Cruz, Yu-Jui Ho, Sharon Lawrence, Jerry P. Melchor, Grant A. Goda, Karen Bai, Alessandro Pastore, Simon J. Hogg, Srivatsan Raghavan, Peter J. Bailey, David K. Chang, Andrew V. Biankin, Kenneth R. Shroyer, Brian M. Wolpin, Andrew J. Aguirre, Andrea Ventura, Barry S. Taylor, Channing J. Der, Daniel Domínguez, Daniel Kümmel, Andrea Oeckinghaus, Scott W. Lowe, Robert K. Bradley, Omar Abdel‐Wahab, Steven D. Leach
Topics & Concepts
Pancreatic cancerRNA splicingMutantCancer researchBiologyRNASignal transductionCell biologyCancerGeneticsGeneRNA modifications and cancerRNA Research and SplicingCancer Genomics and Diagnostics